Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Forbes

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The British Journal of Surgery|May 22, 2007
Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm TrialJ T Powell, L C Brown, J F Forbes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancerW Jonat, M Kaufmann, R W Blamey, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 23, 1999
Early elective open surgical repair of small abdominal aortic aneurysms is not recommended: results of the UK Small Aneurysm Trial. Steering CommitteeR M Greenhalgh, J F Forbes, F G Fowkes, et al.
Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?C Barrios, J F Forbes, W Jonat, et al.
Lancet (London, England)|December 6, 2005
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialD J Adam, J D Beard, T Cleveland, et al.
Breast Cancer Research and Treatment|April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Lancet (London, England)|May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study GroupC Hürny, J Bernhard, A S Coates, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The British Journal of Surgery|May 22, 2007
Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm TrialJ T Powell, L C Brown, J F Forbes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancerW Jonat, M Kaufmann, R W Blamey, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 23, 1999
Early elective open surgical repair of small abdominal aortic aneurysms is not recommended: results of the UK Small Aneurysm Trial. Steering CommitteeR M Greenhalgh, J F Forbes, F G Fowkes, et al.
Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?C Barrios, J F Forbes, W Jonat, et al.
Lancet (London, England)|December 6, 2005
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialD J Adam, J D Beard, T Cleveland, et al.
Breast Cancer Research and Treatment|April 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311Stephen P Ackland, V Gebski, N Zdenkowski, et al.
Lancet (London, England)|May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study GroupC Hürny, J Bernhard, A S Coates, et al.
Pageof 11